UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): December 18,
2009
SKYSTAR
BIO-PHARMACEUTICAL COMPANY
(Exact
name of registrant as specified in Charter)
Nevada
|
000-28153
|
33-0901534
|
||
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File No.)
|
(IRS
Employer Identification No.)
|
Rm.
10601, Jiezuo Plaza, No.4, Fenghui Road South,
Gaoxin District, Xi’an,
Shaanxi Province, P.R. China
(Address
of Principal Executive Offices)
(8629)
8819-3188
(Issuer Telephone
Number)
N/A
(Former name or former address, if
changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item 8.01
|
Other
Events.
|
As
previously reported, on June 25, 2009, Registrant’s board of directors
concluded that 2,000,000 shares of series “A” preferred stock (the “Preferred
Shares”) issued in 2001 were not valid because no certificate of designation was
filed prior to their issuance as required under Nevada corporate
law. On December 21, 2009, Registrant instructed its transfer agent
to remove the Preferred Shares officially from its shareholder records. As a
result, the Preferred Shares will no longer be reported as part of Registrant’s
issued and outstanding capital stock.
Additionally,
effective December 18, 2009, the Registrant appointed Empire Stock Inc.
(“Empire”) as its new transfer agent and registrar. Empire’s address is 1859
Whitney Mesa Drive, Henderson, NV 89014, and its telephone number is (702)
818-5898. The Registrant has made this change in order to increase
its operational efficiency.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
Date: December
22, 2009
|
Skystar
Bio-Pharmaceutical Company
(Registrant)
|
||
By:
|
/s/
Bennet P. Tchaikovsky
|
||
Bennet
P. Tchaikovsky
|
|||
Chief
Financial Officer
|
|||